References
1. Tezze C, Romanello V, Sandri M. Fgf21 as modulator of metabolism in health and disease. Front Physiol . 2019;10:419
2. Hill CM, Qualls-Creekmore E, Berthoud HR, Soto P, Yu S, McDougal DH, et al. Fgf21 and the physiological regulation of macronutrient rreference. Endocrinology . 2020;161
3. Geng L, Lam KSL, Xu A. The therapeutic potential of fgf21 in metabolic diseases: From bench to clinic. Nature reviews. Endocrinology . 2020;16:654-667
4. Taliyan R, Chandran SK, Kakoty V. Therapeutic approaches to alzheimer’s type of dementia: A focus on fgf21 mediated neuroprotection.Curr Pharm Des . 2019;25:2555-2568
5. Zhang Y, Xie Y, Berglund ED, Coate KC, He TT, Katafuchi T, et al. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. Elife . 2012;1:e00065
6. Frayling TM, Beaumont RN, Jones SE, Yaghootkar H, Tuke MA, Ruth KS, et al. A common allele in fgf21 associated with sugar intake is associated with body shape, lower total body-fat percentage, and higher blood pressure. Cell Rep . 2018;23:327-336
7. Kaufman A, Abuqayyas L, Denney WS, Tillman EJ, Rolph T. Akr-001, an fc-fgf21 analog, showed sustained pharmacodynamic effects on insulin sensitivity and lipid metabolism in type 2 diabetes patients. Cell Rep Med . 2020;1:100057
8. Gill D, Burgess S. Use of a genetic variant related to circulating fxa (activated factor x) levels to proxy the effect of fxa inhibition on cardiovascular outcomes. Circ Genom Precis Med . 2020;13:551-553
9. Soberg S, Sandholt CH, Jespersen NZ, Toft U, Madsen AL, von Holstein-Rathlou S, et al. Fgf21 is a sugar-induced hormone associated with sweet intake and preference in humans. Cell Metab . 2017;25:1045-1053 e1046
10. Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLOS Genet . 2014;10
11. Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The mr-base platform supports systematic causal inference across the human phenome. Elife . 2018;7: pii: e34408
12. Pulit SL, Stoneman C, Morris AP, Wood AR, Glastonbury CA, Tyrrell J, et al. Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of european ancestry. Hum Mol Genet . 2019;28:166-174
13. Manning AK, Hivert MF, Scott RA, Grimsby JL, Bouatia-Naji N, Chen H, et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet . 2012;44:659-669
14. Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, et al. Discovery and refinement of loci associated with lipid levels.Nature genetics . 2013;45:1274-1283
15. van der Harst P, Verweij N. Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circ Res . 2018;122:433-443
16. Finngen consortium. Finngen documentation of r4 release, 2020. Web: Https://finngen.Gitbook.Io/documentation/ [accessed date december 10, 2020].
17. Shah S, Henry A, Roselli C, Lin H, Sveinbjornsson G, Fatemifar G, et al. Genome-wide association and mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat Commun . 2020;11:163
18. Nielsen JB, Thorolfsdottir RB, Fritsche LG, Zhou W, Skov MW, Graham SE, et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nature genetics . 2018;50:1234-1239
19. Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet . 2018;50:524-537
20. Mahajan A, Taliun D, Thurner M, Robertson NR, Torres JM, Rayner NW, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps.Nat Genet . 2018;50:1505-1513
21. Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing alzheimer’s disease risk. Nature genetics . 2019;51:404-413
22. Timmers PR, Mounier N, Lall K, Fischer K, Ning Z, Feng X, et al. Genomics of 1 million parent lifespans implicates novel pathways and common diseases and distinguishes survival chances. Elife . 2019;8